High concentration topical capsaicin for chronic neuropathic pain

Neuropathic pain is associated with disability, reduced quality of life and employment, and increased healthcare costs. The prevalence of neuropathic pain in the general...

SHINGRIX now available to millions of vulnerable patients

From 1 November 2023, millions of Australians at risk of severe complications from shingles can receive a Shingrix vaccine under the NIP.

Emergency contraception: forget the checklist

Pharmacists should act as patient champions when it comes to accessing emergency contraception – and that means getting rid of the checklist.

Making sure patients and staff get through this COVID-19 wave

Australia is in the middle of another COVID-19 wave, with case numbers rising sharply since the end of October across the country.

‘April Fool’s day’ for pharmacists and patients as Continued Dispensing ends...

The Easter long weekend is a busy time of year for pharmacists. But 2024 could be the busiest yet, as a major policy change is set to occur.

Do not supply Phenergan to children under 6, manufacturer warns

The TGA has worked with Phenergan manufacturer Sanofi to develop a new contraindication for the medicine in children under 6.